Measured Risk Portfolios’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$5.66K 90
2024
Q4
$5.66K Buy
+100
New +$5.59K 0.01% 210

Other funds holding BMY

Measured Risk Portfolios's BMY Position: Q1 2025 in Review

Measured Risk Portfolios sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 100 shares — an estimated $5.66K sold.

Measured Risk Portfolios first reported a position in BMY in Q4 2024 and held it in 1 quarter. The position peaked at $5.66K in Q4 2024. 2,478 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Measured Risk Portfolios reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Measured Risk Portfolios sold 100 Bristol-Myers Squibb shares in Q1 2025, an estimated $5.66K.
  • Measured Risk Portfolios first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 1 quarter.
  • Measured Risk Portfolios's Bristol-Myers Squibb position peaked at $5.66K in Q4 2024.
  • 2,478 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Measured Risk Portfolios's 13F filing for Q1 2025, filed 13 May 2025.